Insight: Winter 2021

Winter 2021 | 24 Enhancements Legal: California AB 528 Controlled Substances: CURES Database (Low, Chapter 677, Statutes of 2019) expands reporting requirements to include Schedule V drugs and reduces the reporting deadline to one working day from the date the prescription was released to the patient. Legal: CMS To ensure we match the content and requirements per CMS, updated the CMS Notice of Appeals form that is provided to a patient when a claim is rejected for a Medicare plan. y The new expiration date, 02/25/21, now displays in the lower right-hand corner of the form. Legal: New York According to state regulations, prescribers are not permitted to complete prescription information on RxRenewalRequest forms. y Removed the following from the form: − “Please complete this form and fax it back to ###-###-####, or” verbiage − Dr. Dispense as Written line and verbiage − Dr. Substitution Permitted line and verbiage − Authorized By line and verbiage − Printed Name line and verbiage − Date line and verbiage Legal: Ohio Ohio requires pharmacies to submit medical condition/diagnosis code on prescriptions for controlled substances. To comply: y Diagnosis Code(s) was added to the Rx Transfer report for C2-C5 medications. y The Prt C2-5 Dx Print Option was added to the Transferred Rx Report. y The report format was updated to include the pharmacist first and last name for the incoming and outgoing transfer printout and for faxed transfers. Legal: Printed Electronic Prescriptions In compliance with a new rule for outpatient pharmacies, all electronic prescriptions printed for record-keeping purposes must be marked with (COPY) on the face of the prescription. This applies to the Electronic Information for New Prescription from the Prescriber and RxRenewalResponse forms. NRx and PrimeCare 19.1.34